BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7541976)

  • 1. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
    Manley GT; Smitt PS; Dalmau J; Posner JB
    Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
    Dropcho EJ; King PH
    Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma.
    King PH; Dropcho EJ
    Ann Neurol; 1996 May; 39(5):679-81. PubMed ID: 8619556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines.
    Sekido Y; Bader SA; Carbone DP; Johnson BE; Minna JD
    Cancer Res; 1994 Sep; 54(18):4988-92. PubMed ID: 8069866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
    Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
    J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
    Carpentier AF; Rosenfeld MR; Delattre JY; Whalen RG; Posner JB; Dalmau J
    Clin Cancer Res; 1998 Nov; 4(11):2819-24. PubMed ID: 9829748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
    King PH; Redden D; Palmgren JS; Nabors LB; Lennon VA
    J Autoimmun; 1999 Dec; 13(4):435-43. PubMed ID: 10585760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
    Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abdominal complaints and neurological symptoms as an early sign of lung cancer: a manifestation of the anti-Hu syndrome].
    Wymenga AN; Slebos DJ; van der Naalt J; van Putten JW; Peters FT
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):616-9. PubMed ID: 12701397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of epitopic reactivity of the anti-Hu antibody on HuD with and without paraneoplastic syndrome.
    Sodeyama N; Ishida K; Jaeckle KA; Zhang L; Azuma A; Yamada M; Mizusawa H; Wada Y
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):97-9. PubMed ID: 9886463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hu neuronal proteins are expressed in proliferating neurogenic cells.
    Marusich MF; Furneaux HM; Henion PD; Weston JA
    J Neurobiol; 1994 Feb; 25(2):143-55. PubMed ID: 7517436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
    de Beukelaar JW; Verjans GM; van Norden Y; Milikan JC; Kraan J; Hooijkaas H; Sintnicolaas K; Gratama JW; Sillevis Smitt PA
    Cancer Immunol Immunother; 2007 Sep; 56(9):1501-6. PubMed ID: 17597332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
    Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
    J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis.
    Dropcho EJ
    Ann Neurol; 1996 May; 39(5):659-67. PubMed ID: 8619552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural expression profile of Elav-like genes in human brain.
    Schramm M; Falkai P; Pietsch T; Neidt I; Egensperger R; Bayer TA
    Clin Neuropathol; 1999; 18(1):17-22. PubMed ID: 9988134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay.
    Storstein A; Monstad SE; Nakkestad HL; Husebye ES; Vedeler CA
    J Neurol; 2004 Feb; 251(2):197-203. PubMed ID: 14991355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy.
    Molinuevo JL; Graus F; Serrano C; Reñe R; Guerrero A; Illa I
    Ann Neurol; 1998 Dec; 44(6):976-80. PubMed ID: 9851446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer.
    Cho JH; Noguchi M
    J Korean Med Sci; 1997 Aug; 12(4):305-10. PubMed ID: 9288629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.